Our life sciences clients inspire me – I’m driven to work tirelessly and creatively with them to achieve their goals of developing and commercializing innovative healthcare products.

Experience

Morphimmune Announces Merger With Immunome and $125 Million Private Investment

July 5, 2023

Cooley advised Morphimmune, a private biotechnology company, in its definitive merger agreement with Immunome and $125 million private investment.

Read more

Related contacts

Tom Coll
Partner, San Diego
Barbara Borden
Partner, San Diego
Carlos Ramirez
Partner, San Diego
Dylan Kornbluth
Associate, San Diego
Polina A. Demina
Associate, New York
Melissa Meza
Associate, San Diego
Kyrsten Lundh
Associate, San Diego
Daniel Gillon
Associate, San Diego
Nyron J. Persaud
Partner, New York
Todd Gluth
Partner, San Diego
Kay Chandler
Partner, San Diego
Ross Eberly
Partner, Los Angeles Santa Monica
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Sharon Connaughton
Special Counsel, Washington DC
Ajay Athavale
Associate, San Francisco
Joe Mandry
Associate, San Diego
Nathaniel Hearn Jr.
Associate, New York
Terren O'Connor
Associate, San Diego
Daniel Lac
Associate, San Diego
Eileen Leman
Associate, Los Angeles Downtown

Related Practices & Industries

Cholesgen Enters Discovery Collaboration, Licensing Option Agreement With AstraZeneca

June 16, 2023

Cooley advised Cholesgen, a biopharmaceutical company focusing on metabolic diseases, on its three-year research collaboration and licensing agreement with AstraZeneca.

Read more

Related contacts

Christina Zhang
Partner, Shanghai
Freddy Yip
Associate, Hong Kong
Kay Chandler
Partner, San Diego

Related Practices & Industries

Horizon Therapeutics to Be Acquired by Amgen for Approximately $28 Billion

December 20, 2022

A Cooley team advised Horizon Therapeutics, a specialty biopharmaceutical company, on its agreement to be acquired by Amgen. The approximately $28 billion merger would represent the third-largest all-cash transaction in the pharmaceutical sector in history and the biggest healthcare deal of 2022.

 

Read more

Related contacts

Barbara Borden
Partner, San Diego
Kay Chandler
Partner, San Diego
Rama Padmanabhan
Partner, San Diego
Rowook Park
Partner, San Diego
Jacqueline Grise
Partner, Washington DC
Kelly Murata
Paralegal Specialist, San Francisco
Michael Tollini
Partner, Washington DC
Todd Gluth
Partner, San Diego
Lindsey O'Crump
Associate, Washington DC
Edmond Lay
Associate, San Diego
Vivian Tsai
Associate, Los Angeles Santa Monica
Melissa Meza
Associate, San Diego
Peter Adams
Partner, San Diego
Fraser Brown
Partner, Washington DC
Ross Eberly
Partner, Los Angeles Santa Monica
Patrick Van Eecke
Partner, Brussels
David Fletcher
Partner, Washington DC
Caroline Hobson
Partner, London
Alexander Israel
Partner in Charge – Brussels, Brussels
Christopher Kimball
Partner, Washington DC
Mischi a Marca
Partner, San Francisco
Chadwick Mills
Partner, San Francisco
Phil Mitchell
Partner, New York
Alessandra Murata
Partner, Palo Alto
John Paul Oleksiuk
Partner, New York
Michelle Garcia Schulman
Partner, Reston
Lei Shen
Partner, Chicago
Charity Williams
Partner, San Diego
Elizabeth Anne Wright
Partner, Brussels
David Burns
Special Counsel, Washington DC
Sharon Connaughton
Special Counsel, Washington DC
Christine Graham
Special Counsel, London
Natasha Leskovsek
Of Counsel, Washington DC
Rebecca Ross
Special Counsel, Washington DC
Stella Sarma
Special Counsel, Brussels
Matthew D. Silverman
Special Counsel, San Diego
Karen Tsai
Special Counsel, Washington DC
Karun Ahuja
Associate, Chicago
Wade Andrews
Associate, San Diego
Ajay Athavale
Associate, San Francisco
Anna Caro
Associate, London
Umer Chaudhry
Associate, Washington DC
Megan Drill
Associate, San Diego
Andrea Batalla Eguidazu
Associate, London
Michael Fernando
Associate, London
Daniel Gillon
Associate, San Diego
Zack Gong
Associate, Shanghai
Ellie Guadiana
Partner, Los Angeles Santa Monica
Justin Kisner
Special Counsel, Palo Alto
Jessica Koffel
Associate, Brussels
Allison Kutner
Associate, New York
Daniel Lac
Associate, San Diego
Jan Lang
Associate, Brussels
Katie MacDowell
Associate, Reston
Joe Mandry
Associate, San Diego
Hajra Nashin
Associate, San Diego
Dani Nazemian
Special Counsel, San Diego
Linh Nguyen
Associate, San Diego
Allison Wettstein O’Neill
Associate, San Diego
Alexandra Paterson
Associate, London
Addison Pierce
Associate, Chicago
Bartholomäus Regenhardt
Associate, Brussels
Arman Sagart
Associate, San Diego
Grant Schweikert
Special Counsel, Washington DC
Michael Weinstein
Associate, San Diego
Nathaniel Hearn Jr.
Associate, New York
Megan Browdie
Partner, Washington DC

Related Practices & Industries

Biotech Company ViaCyte to Be Acquired by Vertex Pharmaceuticals

July 14, 2022

Cooley advised ViaCyte, a biotechnology company focused on delivering novel stem cell-derived cell replacement therapies as a functional cure for Type 1 diabetes (T1D), on its definitive agreement to be acquired by global biotechnology company Vertex Pharmaceuticals for $320 million in cash. Partners Rowook Park and Carlos Ramirez, along with associate Lindsey O’Crump, led the Cooley team advising ViaCyte.

Read more

Related contacts

Rowook Park
Partner, San Diego
Carlos Ramirez
Partner, San Diego
Jacqueline Grise
Partner, Washington DC
Rama Padmanabhan
Partner, San Diego
Marty Schenker
Senior Counsel , San Francisco
Todd Gluth
Partner, San Diego
Blake Martell
Partner, San Francisco
Kay Chandler
Partner, San Diego
Charity Williams
Partner, San Diego
Jeffrey Karr
Partner, Palo Alto
Ross Eberly
Partner, Los Angeles Santa Monica
Phil Mitchell
Partner, New York
Natasha Leskovsek
Of Counsel, Washington DC
David Burns
Special Counsel, Washington DC
Dina Andrawess
Special Counsel, Palo Alto
Stella Sarma
Special Counsel, Brussels
Arman Sagart
Associate, San Diego
Lindsey O'Crump
Associate, Washington DC
Melissa Meza
Associate, San Diego
Joe Mandry
Associate, San Diego
Julia R. Brinton
Associate, Washington DC
Kimberley Scimeca
Associate, Boston
Daniel Lac
Associate, San Diego
Amanda Griggs
Associate, New York

Related Practices & Industries

Bristol Myers Squibb to Acquire Turning Point Therapeutics for $4.1 Billion

June 4, 2022

Cooley is advising Turning Point Therapeutics, a leading precision oncology company, on its definitive agreement to be acquired by global biopharmaceutical company Bristol Myers Squibb. Lawyers Barbara Borden, Rowook Park, Charles Bair, Lindsey O’Crump, Vivian Tsai and Melissa Meza are leading the Cooley team advising Turning Point Therapeutics.

Read more

Related contacts

Barbara Borden
Partner, San Diego
Rowook Park
Partner, San Diego
Charles Bair
Partner, San Diego
Lindsey O'Crump
Associate, Washington DC
Vivian Tsai
Associate, Los Angeles Santa Monica
Melissa Meza
Associate, San Diego
Kay Chandler
Partner, San Diego
Alessandra Murata
Partner, Palo Alto
Ross Eberly
Partner, Los Angeles Santa Monica
Koji Fukumura
Partner, San Diego
Phil Mitchell
Partner, New York
David Navetta
Partner, Colorado
Todd Gluth
Partner, San Diego
Natasha Leskovsek
Of Counsel, Washington DC
Matthew D. Silverman
Special Counsel, San Diego
Stella Sarma
Special Counsel, Brussels
Christine Graham
Special Counsel, London
Brendan Haberle
Associate, San Diego
Hajra Nashin
Associate, San Diego
Megan Drill
Associate, San Diego
Heidi E. Wang
Associate, San Diego
Eileen Leman
Associate, Los Angeles Downtown
Daniel Gillon
Associate, San Diego
Wade Andrews
Associate, San Diego
Amanda Pacheco
Associate, Palo Alto
Jennifer Shanley
Special Counsel, New York
Daniel Lac
Associate, San Diego

Related Practices & Industries

View more

Rankings & accolades

Chambers USA: Life Sciences: Corporate/Commercial – California & Nationwide (2009 – 2023)

Legal 500: Key Lawyer, Healthcare: Life Sciences (2020 – 2021)

The Best Lawyers in America: Biotechnology Law and Life Sciences 

Southern California Super Lawyers: Securities and Corporate Finance (2007-2009, 2011-2019)

The Best Lawyers in America: San Diego Biotechnology Lawyer of the Year (2011)

Lawdragon: One of 500 dealmakers in America (2007)

Memberships & affiliations

American Bar Association

San Diego County Bar Association